Valiant Laboratories Quarterly Results for Trading Insights
VALIANTLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QSept 2025
Valiant Laboratories Quarterly Results Key Highlights
- Revenue of ₹47 Cr in Sept 2025 (-16.1% vs Mar 2025, +88.0% vs Sept 2024)
- EBITDA of ₹1 Cr in Sept 2025 (-50.0% vs Mar 2025)
- Earnings Per Share of ₹0.04 in Sept 2025 (-75.0% vs Mar 2025)
Valiant Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 47 | 56 | 48 | 25 | 33 | -16.1% | 88.0% |
| Net Profit (₹ Cr) | 0 | 1 | 2 | -5 | -1 | - | - |
| EBITDA (₹ Cr) | 1 | 2 | 3 | -3 | -2 | - | - |
| EPS (₹) | 0.04 | 0.16 | 0.42 | -1.09 | -0.33 | - | - |
| Operating Margin (%) | 0.0% | 7.0% | 5.0% | -31.0% | -15.0% | - | - |
Valiant Laboratories Share Price Trend Around Quarterly Results
Visualize Valiant Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Valiant Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Valiant Laboratories
Additional stock information and data for VALIANTLAB
Revenue Trend (₹ Cr)
Sept 2024
25
Jun 2025
48
Mar 2025
56
Sept 2025
47
Net Profit Trend (₹ Cr)
Sept 2024
-5
Jun 2025
2
Mar 2025
1
Sept 2025
0
Operating Margin Trend (%)
Sept 2024
-31.0%
Jun 2025
5.0%
Mar 2025
7.0%
Sept 2025
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Valiant Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores